Management of Atypical Endometrial Hyperplasia and Endometrial Carcinoma Using Megestrol Acetate

Summary

The purpose of this trial is to study the efficacy, toxicity, and tolerability of a standard hormonal regimen of Megestrol Acetate (Megace) in the treatment of Atypical Endometrial Hyperplasia or well to moderately differentiated endometrial carcinoma.

Timeline

Start

2007-06

Primary completion

2013-10

Completion

2013-10

Drugs

Indications